ATE502305T1 - Verwendung von vorstufen von enkephalinen und/oder deren fragmenten in der medizinischen diagnostik - Google Patents

Verwendung von vorstufen von enkephalinen und/oder deren fragmenten in der medizinischen diagnostik

Info

Publication number
ATE502305T1
ATE502305T1 AT05742347T AT05742347T ATE502305T1 AT E502305 T1 ATE502305 T1 AT E502305T1 AT 05742347 T AT05742347 T AT 05742347T AT 05742347 T AT05742347 T AT 05742347T AT E502305 T1 ATE502305 T1 AT E502305T1
Authority
AT
Austria
Prior art keywords
proenkephalin
fragments
amino acids
enkephalins
precursors
Prior art date
Application number
AT05742347T
Other languages
English (en)
Inventor
Andreas Bergmann
Andrea Ernst
Original Assignee
Brahms Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brahms Gmbh filed Critical Brahms Gmbh
Application granted granted Critical
Publication of ATE502305T1 publication Critical patent/ATE502305T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/665—Assays involving proteins derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • G01N2333/70—Enkephalins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT05742347T 2004-05-13 2005-05-11 Verwendung von vorstufen von enkephalinen und/oder deren fragmenten in der medizinischen diagnostik ATE502305T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04090191 2004-05-13
PCT/EP2005/005090 WO2005114222A1 (en) 2004-05-13 2005-05-11 Use of precursors of enkephalins and/or their fragments in medical diagnostics

Publications (1)

Publication Number Publication Date
ATE502305T1 true ATE502305T1 (de) 2011-04-15

Family

ID=34928803

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05742347T ATE502305T1 (de) 2004-05-13 2005-05-11 Verwendung von vorstufen von enkephalinen und/oder deren fragmenten in der medizinischen diagnostik

Country Status (7)

Country Link
US (1) US8013123B2 (de)
EP (2) EP1745297B1 (de)
JP (1) JP4976282B2 (de)
AT (1) ATE502305T1 (de)
DE (1) DE602005026931D1 (de)
ES (2) ES2363156T3 (de)
WO (1) WO2005114222A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8735085B2 (en) 2007-10-05 2014-05-27 Becton, Dickinson And Company Method for diagnosing diseases using a protein or degradation product based on half-life
EP3358354B1 (de) 2008-01-18 2020-07-15 President and Fellows of Harvard College Verfahren zur detektion von anzeichen einer krankheit oder eines leidens in körperflüssigkeiten
RU2372618C1 (ru) * 2008-04-03 2009-11-10 Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Росздрава" (ГОУ ВПО "НИЖГМА РОСЗДРАВА") Способ экспресс-прогнозирования исходов лечения у больных злокачественными опухолями
SG10201505724SA (en) 2010-07-23 2015-09-29 Harvard College Methods of detecting diseases or conditions using phagocytic cells
US20130203624A1 (en) 2010-07-23 2013-08-08 President And Fellows Of Harvard College Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions
MX382244B (es) 2010-07-23 2025-03-13 Harvard College Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales
CA2806293A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
CN104603289A (zh) 2012-06-15 2015-05-06 哈里·斯泰利 检测疾病或病状的方法
SG11201408383SA (en) 2012-06-15 2015-01-29 Harry Stylli Methods of detecting diseases or conditions using circulating diseased cells
DK3361260T3 (da) * 2012-10-02 2020-08-03 Sphingotec Gmbh En fremgangsmåde til at diagnosticere eller overvåge nyrefunktion
EP2904398B1 (de) * 2012-10-02 2018-04-11 SphingoTec GmbH Verfahren zur vorhersage des risikos von krebs bei einer weiblichen patientin
CA2897245A1 (en) * 2013-01-08 2014-07-17 Sphingotec Gmbh A method for predicting the risk of getting cancer or diagnosing cancer in a subject
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
EP4202441A3 (de) 2013-03-09 2023-07-26 Immunis.AI, Inc. Genexpressionsprofil in makrophagen zur diagnose von krebs
EP2972329A2 (de) * 2013-03-15 2016-01-20 Kinemed, Inc. Biomarker
US10626464B2 (en) 2014-09-11 2020-04-21 Cell Mdx, Llc Methods of detecting prostate cancer
JP6841765B2 (ja) * 2015-04-24 2021-03-10 シュピーンゴテック ゲゼルシャフト ミット ベシュレンクテル ハフツング 慢性腎疾患の発症のリスクを予測するための方法
JP6651493B2 (ja) * 2017-12-05 2020-02-19 チョンシー ユー ペプチド及び関連化合物の経皮送達システム
WO2022071242A1 (ja) * 2020-09-30 2022-04-07 国立大学法人 長崎大学 腎がん患者の抗がん剤抵抗性および予後予測方法、抗腎がん物質のスクリーニング方法、ならびに、腎がん治療用医薬組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4388236A (en) * 1979-08-30 1983-06-14 Hoffmann-La Roche Inc. Enkephalin-like compounds in bovine adrenal medulla
JPS63111465A (ja) * 1986-10-29 1988-05-16 Agency Of Ind Science & Technol ロイシンエンケフアリンのエンザイムイムノアツセイ法
JPH05308992A (ja) * 1992-03-31 1993-11-22 Agency Of Ind Science & Technol モノクローナル抗体
EP1623994A3 (de) * 1999-05-17 2008-07-16 ConjuChem Biotechnologies Inc. Schutz endogener therapeutisch aktiver Peptide vor Peptidaseaktivität durch Konjugation an Blutbestandteile
CA2311201A1 (en) 1999-08-05 2001-02-05 Genset S.A. Ests and encoded human proteins
US20030134301A1 (en) * 2001-07-27 2003-07-17 Brooksbank Robert Alan Identification and use of molecules implicated in pain
ITMI20012205A1 (it) * 2001-10-22 2003-04-22 Nanorganics Llc Metodo e mezzi per l'identificazione precoce di rischi di scompenso cardiaco
WO2003102015A2 (en) * 2002-05-29 2003-12-11 University Of Florida Method and apparatus for detecting and monitoring peptides, and peptides identified therewith

Also Published As

Publication number Publication date
US8013123B2 (en) 2011-09-06
ES2431288T3 (es) 2013-11-25
JP2007537430A (ja) 2007-12-20
ES2363156T3 (es) 2011-07-22
JP4976282B2 (ja) 2012-07-18
DE602005026931D1 (de) 2011-04-28
WO2005114222A1 (en) 2005-12-01
EP2293079A3 (de) 2011-03-30
EP1745297A1 (de) 2007-01-24
EP2293079B1 (de) 2013-08-14
EP1745297B1 (de) 2011-03-16
US20080261232A1 (en) 2008-10-23
EP2293079A2 (de) 2011-03-09

Similar Documents

Publication Publication Date Title
DE602005026931D1 (de) Verwendung von vorstufen von enkephalinen und/oder deren fragmenten in der medizinischen diagnostik
DE60135498D1 (de) Produktion von ganzen Antikörpern in prokaryontischen Zellen
IS8432A (is) Mótefni sem bindast viðtaka hvítfrumuboða-4
DE60333963D1 (de) Zytokin Ligand zur Behandlung von Asthma und Atemwegsüberreaktivität
DK1626985T3 (da) Generering af kunstige bindingsproteiner på basis af ubiquitin proteiner
CY1109715T1 (el) IL-1β ΔΕΣΜΕΥΤΙΚΑ ΑΝΤΙΣΩΜΑΤΑ ΚΑΙ ΘΡΑΥΣΜΑΤΑ ΑΥΤΩΝ
MX2009013824A (es) Proteinas de enlace de antigeno que enlazan par-2.
NZ596409A (en) Anti macrophage migration inhibitory factor antibodies
UA96139C2 (uk) Антитіло до нейропіліну-1 (nrp1)
DE60130538D1 (de) Humanisierte antikörper gegen ccr2 und verfahren zur deren verwendung
BR0315161A (pt) Anticorpo isolado, polinicleotìdeo isolado, vetor, célula hospedeira, método de produzir um anticorpo, e, composição
EP2805970A3 (de) Antikörper gegen GDF8 und ihre Verwendung
DE19207796T1 (de) Antigen zur bindung von proteinen an proprotein-konvertase-subtilisin/kexin vom typ 9 (pcsk9)
DE60224291D1 (de) System zur antikörperexpression und- synthese
BR112012003064B8 (pt) anticorpo ou fragmento de ligação de antígeno do mesmo, combinação que os compreende, método de detecção de infecção por rsv, moléculas de ácido nucléico, e método de produção de um anticorpo ou fragmento de ligação de antígeno do mesmo
Jensen et al. Granzyme B degraded type IV collagen products in serum identify melanoma patients responding to immune checkpoint blockade
JP2008530138A5 (de)
EP2628746A3 (de) Verfahren zur Konzentration eines Polypeptids
TW200626614A (en) Human monoclonal antibodies to influenza M2 protein and methods of making and using same
WO2006110214A3 (en) Antibodies against mammalian metapneumovirus
ATE429445T1 (de) Verfahren zur herstellung von carboxy-terminal amidierten peptiden
ATE460430T1 (de) Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
ATE485517T1 (de) Verfahren zur identifizierung von polypeptid- targets
DE602007009116D1 (de) Zusammensetzungen und verfahren zur verabreichung anti-aktivierter ras-antikörper an zellen
WO2004094476A3 (en) Compositions and methods relating to stop-1

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1745297

Country of ref document: EP